Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selectis HealthGBCS 47 Receivables Turnover is 3.06 as of Mar. 2026. GuruFocus rates GBCS with a GF Score™ of 47/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Selectis Health ranks better than 74.09% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Selectis Health's Revenue for the
three
months ended in Mar. 2026 was $7.29 Mil. Selectis Health's average Accounts Receivable for the
three
months ended in Mar. 2026 was $2.38 Mil.
Hence, Selectis Health's Receivables Turnover for the
three
months ended in Mar. 2026 was 3.06.
Selectis Health (OTCPK:GBCS) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Selectis Health Receivables Turnover Related Terms
Selectis Health Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Selectis Health's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GBCS vs CCM, BMGL, AMS: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Selectis Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Selectis Health's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a Receivables Turnover of 3.06 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #171 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 25.9%.
Is Selectis Health's Receivables Turnover too high?
Selectis Health's current Receivables Turnover is 3.06. The Healthcare Providers & Services industry median Receivables Turnover is 7.75. Selectis Health's value of 3.06 is 60.5% below this industry median. Based on the distribution chart, Selectis Health ranks #171 out of 660 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Selectis Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Receivables Turnover compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #171 out of 660 companies for Receivables Turnover. This puts Selectis Health in the upper half of its industry. The industry median Receivables Turnover is 7.75. Selectis Health's value of 3.06 is 60.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current Receivables Turnover of 3.06 is 60.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current Receivables Turnover is 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.30 — trading 147.7% above its estimated fair value. The current Receivables Turnover is 3.06 and 60.5% below the Healthcare Providers & Services industry median of 7.75. Selectis Health's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Selectis Health (GBCS), the current Receivables Turnover is 3.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.30 is trading 147.7% above its estimated GF Value™ of $2.14.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
Receivables Turnover: 3.06
GF Value™: $2.14 vs. price of $5.30 (147.7% above fair value)
Industry Position: 60.5% below the Healthcare Providers & Services median (#171 of 660)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
47GF Score
Get the complete analysis for GBCS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
